Working with founders and executive management teams from startups to major internationals for over 25 years acting as an adviser and their interface with the investment community.Focused on Venture/Scale Up stage businesses across all sectors with a particular interest in Digital/Tech and a specialism in Life Sciences/Healthcare.Global perspective; recent clients in North America, Europe and the Middle East: leading digital video art platform, workplace wellness platform, AI Healthcare startup, longevity business and financial services.Highly effective at Business Development and Corporate Development due to my analytical skill set and relationship building.Vast experience in Corporate Finance transactions - deal sheet available on request.Strong background in finance and funding including making investment decisions and managing portfolios.BACKGROUNDStarted my career at EY where I analysed and advised Entrepreneurial growth businesses across a wide variety of sectors winning a national prize for my work.Over 10 years in the City (Goldman Sachs, Citi, Société Générale) analysing Pharma, Biotech and Healthcare companies and providing strategic advice to investors and corporate management in my various roles.Moved into Venture Capital and helped build and scale up a VC startup business sold for £20m in 2017.We established the first ever tax efficient annual VC seed fund for the University of Cambridge in 2012. Now in its eighth year and has raised millions of pounds annually to invest in companies spun out of the University of Cambridge.Model successfully replicated at the University of Oxford, University of Bristol and Imperial College London thereby creating an entirely new area of funding.Helped introduce a similar tax efficient VC funding policy to Australia which has had a very positive impact on its startup scene from 2016.Please see www.G2.VC or contact me for more details.